Neuroadaptational changes in DNA binding of stimulatory protein-1 and nuclear factor-kB gene transcription factors during ethanol dependence

European Journal of Pharmacology

Volumn 386, Issue 1, 1999, Pages 113-119

  Mittal, Navdha ^a   Nathan, Joshua B ^a   Pandey, Subhash C ^a  

^a NONE

Author keywords

Brain; Ethanol dependence; Ethanol tolerance; NF kB (nuclear factor kB) gene transcription factor; SP1 (stimulatory protein 1) gene transcription factor

Indexed keywords

ALCOHOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR SP1;

ALCOHOL TOLERANCE; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DNA BINDING; GENETIC TRANSCRIPTION; HIPPOCAMPUS; MALE; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT;

ADAPTATION, PHYSIOLOGICAL; ALCOHOLISM; ANIMALS; AUTORADIOGRAPHY; BRAIN CHEMISTRY; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CEREBRAL CORTEX; DNA; DNA-BINDING PROTEINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ETHANOL; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MALE; NERVOUS SYSTEM; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; SP4 TRANSCRIPTION FACTOR;

EID: 0033458089     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00734-7     Document Type: Article

References (39)

1. Ammendola R., Mesuraca M., Russo T., Cimino F. SP1 DNA binding efficiency is highly reduced in nuclear extracts from aged rat tissues. J. Biol. Chem. 267:1992;17944-17948.
2. Ammendola R., Mesuraca M., Russo T., Cimino F. The DNA-binding efficiency of SP1 is affected by redox changes. Eur. J. Biochem. 225:1994;483-489.
3. Baeuerle P.A., Baltimore D. NF-kB: ten years after. Cell. 87:1996;13-20.
4. Briggs M.R., Kadonaga J.T., Bell S.P., Tjian R. Purification and biochemical characterization of the promoter-specific transcription factor SP1. Science. 234:1986;47-52.
5. Crabbe J.C., Philips T.J., Buck K.J., Cunningham C.L., Belknap J.K. Identifying genes for alcohol and drug sensitivity: recent progress and future directions. Trends Neurosci. 22:1999;173-179.
6. Crespi F. The role of cholecystokinin (CCK), CCK-A or CCK-B receptor antagonists in the spontaneous preference for drugs of abuse (alcohol or cocaine) in naive rats. Methods Find. Exp. Clin. Pharmacol. 20:1998;679-697.
7. Fadda F., Rossetti Z.L. Chronic ethanol consumption: from neuroadaptation to neurodegeneration. Prog. Neurobiol. 56:1998;385-431.
8. Goldman D. Candidate genes in alcoholism. Clin. Neurosci. 3:1995;174-181.
9. Grant K.A., Lovinger D.M. Cellular and behavioral neurobiology of alcohol: receptor-mediated neuronal process. Clin. Neurosci. 3:1995;155-164.
10. Grant K.A., Volverius P., Hudspith M., Tabakoff B. Ethanol withdrawal seizures and NMDA receptor complex. Eur. J. Pharmacol. 176:1990;289-296.
11. Harada S., Okubo T., Tsutsumi M., Takase S., Muramatsu T. A new genetic variant in the SP1 binding Cis-element of cholecystokinin gene promoter region and relationship to alcoholism. Alcohol.: Clin. Exp. Res. 22:1998;93S-96S.
12. Harro J., Wahlstrom G., Oreland L. Cholecystokinin receptor binding after long-term ethanol treatment in rats. Alcohol Alcohol. 29:1994;575-581.
13. Ishiguro H., Saito T., Shibuya H., Toru M., Arinami T. No association between C-45T polymorphism in the SP1 binding site of the promoter region of the cholecystokinin gene and alcoholism. Psychiatry Res. 85:1999;209-213.
14. Jackson S.P., MacDonald J.J., Lees-Miller S., Tjian R. GC box binding induces phosphorylation of SP1 by a DNA-dependent protein kinase. Cell. 63:1990;155-165.
15. Koob G.F., Sanna P.P., Bloom F.E. Neuroscience of addiction. Neuron. 21:1998;467-476.
16. LeMarquand D., Pihl R.O., Benkelfat C. Serotonin and alcohol intake, abuse and dependence: findings of animal studies. Biol. Psychiatry. 36:1994;395-421.
17. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
18. Mandreker P., Catalano D., Szabo G. Alcohol-induced regulation of nuclear regulatory factor-Kβ in human monocytes. Alcohol.: Clin. Exp. Res. 21:1997;988-994.
19. Meberg P.J., Kinney W.R., Valcourt E.G., Routtenberg A. Gene expression of the transcription factor NF-kB in hippocampus: regulation by synaptic activity. Mol. Brain Res. 38:1996;179-180.
20. Murthy R.C., Saxena D.K., Lal B., Chandra S.V. Chronic cadmium-ethanol administration alters metal distribution and some biochemicals in rat brain. Biochem. Int. 19:1989;135-143.
21. Nielsen F.C., Pedersen K., Hansen T.V.O., Rourke I.J., Rehfeld J.F. Transcriptional regulation of the human cholecystokinin gene: composite action of upstream stimulatory factor, SP1, and members of the CREB/ATF-AP-1 family of transcription factors. DNA Cell Biol. 15:1996;53-63.
22. Okubo T., Harada S., Higuchi S., Matsushita S. Genetic association between alcohol withdrawal symptoms and polymorphism of CCK gene promoter. Alcohol.: Clin. Exp. Res. 23:1999;11S-12S.
23. O'Neill L.A.J., Kaltschmidt C. NF-kB: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 20:1997;252-258.
24. Oreland L., Wiberg A., Winblad B. The activity of monoamine oxidase A and B in brains from chronic alcoholics. J. Neural Transm. 56:1983;73-83.
25. q/11 α subunit protein and phospholipase C isozymes in the rat brain. J. Neurochem. 67:1996;2355-2361.
26. Pandey S.C. Neuronal signaling systems and ethanol dependence. Mol. Neurobiol. 17:1998;1-15.
27. 2A/2C receptors and these receptor-linked phosphoinositide system by ethanol. Behav. Brain Res. 73:1996;235-238.
28. Pandey S.C., Zhang D., Mittal N., Nayyar D. Potential role of the gene transcription factor cyclic AMP-responsive element binding protein in ethanol withdrawal-related anxiety. J. Pharmacol. Exp. Ther. 288:1999;866-878.
29. α6 receptors and the serotonin transporter in the level of response to alcohol: a pilot study. Biol. Psychiatry. 45:1999;647-651.
30. Sheriff F., Wahlstrom G., Oreland L. Brain GABA-transaminase and monoamine oxidase after chronic ethanol treatment in rats. Alcohol.: Clin. Exp. Res. 17:1993;1313-1318.
31. Tabakoff B., Hoffman P.L. Alcohol addiction: an enigma among us. Neuron. 16:1996;909-912.
32. VonKnorring A.L., Bohman M., VonKnorring L., Oreland L. Platelet MAO activity as a biological marker in subgroups of alcoholism. Acta Psychiatr. Scand. 72:1985;51-58.
33. VonKnorring A.L., Hallman J., VonKnorring L., Oreland L. Platelet monoamine oxidase activity in type 1 and type 2 alcoholism. Alcohol Alcohol. 26:1991;409-416.
34. Wiberg A., Wahlstrom G., Oreland L. Brain monoamine oxidase activity after chronic ethanol treatment of rats. Psychopharmacology. 52:1977;111-113.
35. Wilson J., Watson W.P., Little H.J. CCK (B) antagonists protect against anxiety-related behavior produced by ethanol withdrawal, measured using the elevated plus-maze. Psychopharmacology. 137:1998;120-131.
36. Yang X., Horn K., Wand G.S. Chronic ethanol exposure impairs phosphorylation of CREB and CRE-DNA binding activity in rat striatum. Alcohol.: Clin. Exp. Res. 22:1998;382-390.
37. Zakhari S., Szabo G. NF-kB, a prototypical cytokine-regulated transcription factor: implications for alcohol-mediated responses. Alcohol.: Clin. Exp. Res. 20:1996;236A-242A.
38. Zhu Q.-S., Grimsby J., Chen K., Shih J.C. Promoter organization and activity of human monoamine oxidase (MAO) A and B genes. J. Neurosci. 12:1992;4437-4446.
39. Zhu Q.S., Chen K., Shih J.C. Bidirectional promoter of human monoamine oxidase A (MAOA) controlled by transcription factor SP1. J. Neurosci. 14:1994;7393-7403.